Krensavage Asset Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1609251
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,741,240
+$650,680 QoQ
Shares Held
6,000
+50.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#421
of 1,322 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Krensavage Asset Management, LLC holds $164,705,918 across 9 Biotechnology names. REGN ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ENTA |
Enanta Pharmaceuticals Inc
|
2,866,138 | $41,788,292 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
167,816 | $40,438,621 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
524,786 | $30,028,254 | |
| 4 | EXEL |
Exelixis, Inc.
|
370,693 | $20,169,406 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
390,879 | $13,051,449 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
1,180,388 | $7,223,974 | |
| 7 | BNTX |
BioNTech SE
|
59,523 | $5,538,615 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
6,000 | $3,741,240 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,741,240 | 6,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,090,560 | 4,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,087,480 | 4,000 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,249,080 | 4,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,100,000 | 4,000 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $371,087 | 353 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $8,253,738 | 7,853 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $12,025,350 | 12,494 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $41,504,472 | 47,256 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $38,889,797 | 47,256 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $42,528,945 | 59,188 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $48,879,504 | 59,488 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $43,363,713 | 60,103 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $41,944,605 | 60,889 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $35,694,793 | 60,384 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $46,710,329 | 66,880 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $43,625,401 | 69,080 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $44,264,680 | 73,143 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $45,858,368 | 82,104 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $39,127,731 | 82,698 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $39,711,642 | 82,200 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $46,046,383 | 82,258 | Shares | Sole | 2020-12-08 | |
| 2020-06-30 | $49,699,292 | 79,691 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $42,391,872 | 86,817 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||